| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. …
Over the last 12 months, insiders at Aethlon Medical, Inc. have bought $0 and sold $0 worth of Aethlon Medical, Inc. stock.
On average, over the past 5 years, insiders at Aethlon Medical, Inc. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2020-12-17 | Sale | Shah Chetan | director | 26,852 0.2008% | $2.11 | $56,580 | +15.02% | |
| 2010-04-13 | Sale | BROENNIMAN EDWARD G | director | 9,800 0.015% | $0.34 | $3,283 | ||
| 2010-04-12 | Sale | BROENNIMAN EDWARD G | director | 25,000 0.0383% | $0.34 | $8,375 | ||
| 2010-04-09 | Sale | BROENNIMAN EDWARD G | director | 25,000 0.0381% | $0.33 | $8,338 | ||
| 2010-04-08 | Sale | BROENNIMAN EDWARD G | director | 25,000 0.0383% | $0.34 | $8,375 | ||
| 2010-04-07 | Sale | BROENNIMAN EDWARD G | director | 24,000 0.0395% | $0.35 | $8,400 | ||
| 2010-04-07 | Sale | BARRY FRANKLYN S JR | director | 8,800 0.0145% | $0.35 | $3,080 | ||
| 2010-04-06 | Sale | BROENNIMAN EDWARD G | director | 23,800 0.0359% | $0.35 | $8,330 | ||
| 2010-04-06 | Sale | BARRY FRANKLYN S JR | director | 23,800 0.0359% | $0.35 | $8,330 | ||
| 2010-04-05 | Sale | BROENNIMAN EDWARD G | director | 23,000 0.0348% | $0.35 | $8,073 | ||
| 2010-04-05 | Sale | BARRY FRANKLYN S JR | director | 23,000 0.0348% | $0.35 | $8,073 | ||
| 2010-04-01 | Sale | BROENNIMAN EDWARD G | director | 22,800 0.0354% | $0.37 | $8,436 | ||
| 2010-04-01 | Sale | BARRY FRANKLYN S JR | director | 22,800 0.0354% | $0.37 | $8,436 | ||
| 2010-03-31 | Sale | BROENNIMAN EDWARD G | director | 22,000 0.0328% | $0.36 | $8,030 | ||
| 2010-03-31 | Sale | BARRY FRANKLYN S JR | director | 22,000 0.033% | $0.37 | $8,074 | ||
| 2010-03-30 | Sale | BROENNIMAN EDWARD G | director | 22,000 0.041% | $0.38 | $8,360 | ||
| 2010-03-30 | Sale | BARRY FRANKLYN S JR | director | 22,000 0.0404% | $0.37 | $8,239 | ||
| 2010-03-29 | Sale | BROENNIMAN EDWARD G | director | 22,000 0.0384% | $0.39 | $8,470 | ||
| 2010-03-29 | Sale | BARRY FRANKLYN S JR | director | 22,000 0.0377% | $0.38 | $8,327 | ||
| 2010-03-26 | Sale | BROENNIMAN EDWARD G | director | 20,000 0.0362% | $0.41 | $8,200 |
| Increased Positions | 4 | +13.79% | 2,052 | +3.94% |
| Decreased Positions | 14 | -48.28% | 37,675 | -72.31% |
| New Positions | <1 | New | <1 | New |
| Sold Out Positions | 11 | Sold Out | 36,459 | Sold Out |
| Total Postitions | 19 | -34.48% | 16,478 | -68.37% |
| Ikarian Capital, Llc | $43.00 | 1.54% | 15,366 | 0 | 0% | 2025-09-30 |
| Hrt Financial Lp | $37.00 | 1.31% | 13,060 | +13,060 | New | 2025-09-30 |
| Citadel Advisors Llc | $27.00 | 0.95% | 9,508 | +9,508 | New | 2025-09-30 |
| Renaissance Technologies Llc | $13.00 | 0.46% | 4,600 | +4,600 | New | 2025-09-30 |
| Scientech Research Llc | $7.00 | 0.26% | 2,599 | +2,599 | New | 2025-09-30 |
| Two Sigma Investments, Lp | $6.00 | 0.2% | 2,027 | +2,027 | New | 2025-09-30 |
| Xtx Topco Ltd | $4.00 | 0.16% | 1,549 | +1,549 | New | 2025-09-30 |
| Two Sigma Securities, Llc | $4.00 | 0.15% | 1,468 | +1,468 | New | 2025-09-30 |
| Geode Capital Management, Llc | $4.00 | 0.14% | 1,347 | 0 | 0% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $1.00 | 0.03% | 299 | +228 | +321.13% | 2025-09-30 |